Senior insider sale
TRANSPHORM, INC. — senior position signals high conviction
$8.8K
3.23K shares
What this filing means
SMALES KELLY plans to sell 3.23K shares of TRANSPHORM, INC. valued at approximately $8.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/17/2023ACC: 0001970051-23-000021
3.23K
Shares to sell
$8.8K
Approx. market value
3.23K
Acquired (3 months)
2
Planned
Securities Acquired — Last 3 Months1
Common Stock
COMPENSATORY PAYMENT
11/17/2023
3.23KTotal acquired3.23K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/17/2023 | Common Stock COMPENSATORY PAYMENT | 3.23K | — |
| Total | 3.23K | ||
Planned & Completed Dispositions2
NASDAQPlanned
Units to sell
2.19K
Market value
$5.8K
11/17/2023
NASDAQPlanned
Units to sell
1.04K
Market value
$2.9K
11/17/2023
Total
Units
3.23K
Value
$8.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/17/2023 | 2.19K | $5.8K | NASDAQ | Planned |
11/17/2023 | 1.04K | $2.9K | NASDAQ | Planned |
| Total | 3.23K | $8.8K | ||